Skip to content
Loading Events

« All Events

  • This event has passed.

Capital Markets Update / State of the Economy

May 21 @ 12:00 pm 1:15 pm

FREE Webinar:
Capital Markets Update / State of the Economy

Tuesday, May 21, 2024 | 12:00 p.m.-1:15 p.m.

Join us for this insightful webinar where we’ll dive into crucial topics shaping the financial landscape. Our experts will discuss M&A collaborations and deals, emerging technologies garnering funding and the impacts of the IRA. Plus, you’ll gain valuable insights into the upcoming 2024 election’s potential ramifications on the economy. Don’t miss this opportunity to stay ahead in today’s dynamic market environment. Topics include:

  • M & A Collaborations & Deals
  • Technologies that are being funded and those that are not
  • IRA and its Impacts 
  • Upcoming 2024 Election

Mr. Gaub oversees Capital Markets, Financial Risk Management, International Treasury & International Treasury Operations, Cash Leadership and Benefit Investments.  Prior to joining BMS, he worked at Zoetis for nine years, most recently serving as Senior Director of Investor Relations, where he managed relationships with sell-side analysts and large institutional investors, in addition to supporting their CEO and CFO during earnings announcements.

Ms. McCaffrey drives market-leading insight around geopolitics, corporate performance and political risk management. She leads the analysis of the annual EY Geostrategic Outlook and advises clients on how geopolitical developments may impact their companies’ operations and strategies, and how to manage political risks more proactively. She is also the co-author of a forthcoming book entitled Geostrategy by Design: How to Manage Geopolitical Risk in the New Era of Globalization.

Mr. Morley is a Senior Managing Director in Leerink Partners’ Equity Capital Markets group, advising private and public healthcare companies on the optimal strategy and tactics to achieve their financing goals. He joined the Firm in 2011 as a member of the Healthcare Investment Banking group before transitioning to his current role. 

Mr. Sclafani has deep experience supporting branded, biotech, generics, medical device and other healthcare companies. He leads high performing teams to address his clients most challenging issues across strategy, operations, digital & analytics, compliance and technology in the Pharma commercial organization, medical affairs, M&A / business development and other key functions.

Mr. van den Akker is PwC’s Pharmaceutical and Life Sciences Deals Leader, with vast experience in transactions, deals, M&A and divestitures. He leads a team focused on helping pharma, life sciences and med tech companies win through deals and seamlessly capture value during acquisitions.

Leveraging his extensive experience as a biopharma senior executive, Mr. Megaffin has guided both public and private companies as CEO and Board Director. His deep knowledge spans a broad range of therapeutic areas, including immunology, inflammation, oncology, anti-infectives, pain, critical care and virology. He currently applies his expertise beyond Adiso by serving on the board of BioNJ and Adastra.

Whether you’re involved in M&A, technology, finance or in the broader economic landscape, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost.

Who should attend this webinar: This webinar is ideal for financial professionals, investors, business leaders, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy.

© 2024 BioNJ, All Rights Reserved